INSIGHTS ON CLINICAL TRIAL DESIGN
-
Rethinking Trial Access Through Trust-Driven Design And Local Collaboration
Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
-
The Difference Between Clinical Trial Auditing And Monitoring
While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.
-
Beyond Help Desk: RTSM Support Ready For Change
This clip explores what sponsors should expect from an RTSM support model built for long‑term study needs, emphasizing capacity, flexibility, and readiness to adapt as trials evolve.
-
The Hidden Complexity Of Ophthalmic Protocol Requirements
Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.
-
Navigating Tension Of Clinical Equipoise In Precision Oncology Trials5/5/2026
This roundtable discussion examines the tension between legacy methods and modern innovation, exploring the complexities of hybrid trial designs and the changing regulatory landscape.
-
Challenges And New Approaches To Developing Clinical Evidence For Medical Devices9/12/2024
Learn about the challenges and new approaches to developing clinical evidence for medical devices, including decentralized trials, adaptive studies, in silico trials, and real-world evidence.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Decentralized And Community-Based Solutions Driving Women's Healthcare9/24/2025
Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.
-
Cohort Configuration Feature Of An RTSM Platform3/16/2026
Master trial agility by building and prioritizing cohorts in real time. Effortlessly manage dose levels and enrollment limits to keep your study on track, even as protocols evolve.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.